{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:45:10Z","timestamp":1791477910911,"version":"4.3.4"},"reference-count":101,"publisher":"Informa UK Limited","issue":"9","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncol."],"published-print":{"date-parts":[[2017,4,30]]},"DOI":"10.2217\/fon-2016-0266","type":"journal-article","created":{"date-parts":[[2017,1,27]],"date-time":"2017-01-27T08:31:16Z","timestamp":1485505876000},"page":"809-819","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":55,"title":["Difluoromethylornithine in Cancer: New Advances"],"prefix":"10.1080","volume":"13","author":[{"given":"Alexiou","family":"George A","sequence":"first","affiliation":[{"name":"Neurosurgical Institute, Ioannina University School of Medicine, Ioannina, GR 451 10, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianos","family":"Georgios D","sequence":"additional","affiliation":[{"name":"Neurosurgical Institute, Ioannina University School of Medicine, Ioannina, GR 451 10, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ragos","family":"Vassileios","sequence":"additional","affiliation":[{"name":"Neurosurgical Institute, Ioannina University School of Medicine, Ioannina, GR 451 10, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galani","family":"Vasiliki","sequence":"additional","affiliation":[{"name":"Department of Anatomy-Histology-Embryology, Medical School, University of Ioannina, 45110 Ioannina, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyritsis","family":"Athanassios P","sequence":"additional","affiliation":[{"name":"Neurosurgical Institute, Ioannina University School of Medicine, Ioannina, GR 451 10, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2017,1,27]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pdpdt.2008.03.001"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)38070-0"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2011.09.007"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00726-004-0092-6"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj20030382"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/0277-5379(87)90141-6"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/0090-4295(86)90154-8"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01630718"},{"issue":"3","key":"e_1_3_3_10_1","first-page":"226","article-title":"Translational development of difluoromethylornithine (DFMO) for the treatment of neuroblastoma","volume":"4","author":"Bassiri H","year":"2015","unstructured":"Bassiri H , BenavidesA, HaberM, GilmourSK, NorrisMD, HogartyMD. Translational development of difluoromethylornithine (DFMO) for the treatment of neuroblastoma. Transl. Pediatr.4(3), 226\u2013238 (2015).","journal-title":"Transl. Pediatr."},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1500729"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0017510"},{"key":"e_1_3_3_13_1","unstructured":"ClinicalTrials.gov\n. Chemoprevention of gastric carcinogenesis. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02794428?term=TARGETED+CHEMOPREVENTION+OF+GASTRIC+CARCINOGENESIS+IN+HIGH+RISK+POPULATIONS&rank=1."},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.4668-14.2015"},{"key":"e_1_3_3_15_1","unstructured":"ClinicalTrials.gov\n. DFMO in children with Type 1 diabetes. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02384889?term=dfmo&rank=5."},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-1033.1986.tb09544.x"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.381335"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.96.3.762"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molbiopara.2008.03.008"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pt.2003.09.002"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00726-007-0531-2"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.35386"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-3213"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00726-007-0534-z"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.CAPR-09-0248"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5829.2011.00264.x"},{"issue":"3","key":"e_1_3_3_27_1","first-page":"981","article-title":"Phase III randomized study of postradiotherapy chemotherapy with combination alpha-difluoromethylornithine-PCV versus PCV for anaplastic gliomas","volume":"9","author":"Levin VA","year":"2003","unstructured":"Levin VA , HessKR, ChoucairAet al. Phase III randomized study of postradiotherapy chemotherapy with combination alpha-difluoromethylornithine-PCV versus PCV for anaplastic gliomas. Clin. Cancer Res.9(3), 981\u2013990 (2003).","journal-title":"Clin. Cancer Res."},{"issue":"10","key":"e_1_3_3_28_1","first-page":"3878","article-title":"Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N\u2019-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme","volume":"6","author":"Levin VA","year":"2000","unstructured":"Levin VA , UhmJH, JaeckleKAet al. Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N\u2019-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme. Clin. Cancer Res.6(10), 3878\u20133884 (2000).","journal-title":"Clin. Cancer Res."},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(00)01458-9"},{"issue":"5","key":"e_1_3_3_30_1","first-page":"459","article-title":"Phase I\u2013II study of eflornithine and mitoguazone combined in the treatment of recurrent primary brain tumors","volume":"71","author":"Levin VA","year":"1987","unstructured":"Levin VA , ChamberlainMC, PradosMDet al. Phase I\u2013II study of eflornithine and mitoguazone combined in the treatment of recurrent primary brain tumors. Cancer Treat. Rep.71(5), 459\u2013464 (1987).","journal-title":"Cancer Treat. Rep."},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/84.18.1432"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.CAPR-15-0232"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.CAPR-12-0233"},{"issue":"6","key":"e_1_3_3_34_1","first-page":"355","article-title":"Chemopreventive efficacy of topical difluoromethylornithine and\/or triamcinolone in the treatment of actinic keratoses analyzed by karyometry","volume":"31","author":"Bartels P","year":"2009","unstructured":"Bartels P , YozwiakM, EinspahrJet al. Chemopreventive efficacy of topical difluoromethylornithine and\/or triamcinolone in the treatment of actinic keratoses analyzed by karyometry. Anal. Quant. Cytol. Histol.31(6), 355\u2013366 (2009).","journal-title":"Anal. Quant. Cytol. Histol."},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2014-307235"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.CAPR-08-0042"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-07-0658"},{"issue":"10","key":"e_1_3_3_38_1","first-page":"907","article-title":"Phase I chemoprevention study of piroxicam and alpha-difluoromethylornithine","volume":"7","author":"Carbone PP","year":"1998","unstructured":"Carbone PP , DouglasJA, LarsonPOet al. Phase I chemoprevention study of piroxicam and alpha-difluoromethylornithine. Cancer Epidemiol. Biomarkers Prev.7(10), 907\u2013912 (1998).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/0277-5379(87)90141-6"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/0090-4295(86)90154-8"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0127246"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.2176\/nmc.35.215"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01410129"},{"issue":"1","key":"e_1_3_3_44_1","first-page":"175","article-title":"Inhibition of the growth of U-251 human glioblastoma in nude mice by polyamine deprivation","volume":"11","author":"Moulinoux JP","year":"1991","unstructured":"Moulinoux JP , DarcelF, QuemenerV, HavouisR, SeilerN. Inhibition of the growth of U-251 human glioblastoma in nude mice by polyamine deprivation. Anticancer Res.11(1), 175\u2013179 (1991).","journal-title":"Anticancer Res."},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1986.65.5.0671"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0080076"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1179\/1973947813Y.0000000117"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgg046"},{"issue":"15","key":"e_1_3_3_49_1","first-page":"3610","article-title":"Difluoromethylornithine chemoprevention of epidermal carcinogenesis in K14-HPV16 vtransgenic mice","volume":"59","author":"Arbeit JM","year":"1999","unstructured":"Arbeit JM , RileyRR, HueyBet al. Difluoromethylornithine chemoprevention of epidermal carcinogenesis in K14-HPV16 vtransgenic mice. Cancer Res.59(15), 3610\u20133620 (1999).","journal-title":"Cancer Res."},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4644(1997)28\/29 <81::AID-JCB9>3.0.CO;2-S"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01630718"},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.CAPR-11-0067"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.1002\/mc.20246"},{"key":"e_1_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/23.9.1447"},{"issue":"5","key":"e_1_3_3_55_1","first-page":"3485","article-title":"In vivo growth inhibition of human colon carcinoma cells (HT-29) by all-trans-retinoic acid, difluoromethylornithine, and colon mitosis inhibitor, individually and in combination","volume":"20","author":"Paulsen JE","year":"2002","unstructured":"Paulsen JE , L\u00fctzow-HolmC. In vivo growth inhibition of human colon carcinoma cells (HT-29) by all-trans-retinoic acid, difluoromethylornithine, and colon mitosis inhibitor, individually and in combination. Anticancer Res.20(5B), 3485\u20133489 (2002).","journal-title":"Anticancer Res."},{"issue":"7","key":"e_1_3_3_56_1","first-page":"1864","article-title":"Chemopreventive efficacy of combined piroxicam and difluoromethylornithine treatment of Apc mutant Min mouse adenomas, and selective toxicity against Apc mutant embryos","volume":"60","author":"Jacoby RF","year":"2000","unstructured":"Jacoby RF , ColeCE, TutschKet al. Chemopreventive efficacy of combined piroxicam and difluoromethylornithine treatment of Apc mutant Min mouse adenomas, and selective toxicity against Apc mutant embryos. Cancer Res.60(7), 1864\u20131870 (2000).","journal-title":"Cancer Res."},{"key":"e_1_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/20.3.425"},{"key":"e_1_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.CAPR-14-0176"},{"key":"e_1_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006676-198902000-00006"},{"key":"e_1_3_3_60_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00173644"},{"issue":"3","key":"e_1_3_3_61_1","first-page":"543","article-title":"Treatment of hamster pancreatic cancer with alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis","volume":"79","author":"Marx M","year":"1987","unstructured":"Marx M , TownsendCMJr, BarrancoSC, GlassEJ, ThompsonJC. Treatment of hamster pancreatic cancer with alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis. J. Natl Cancer Inst.79(3), 543\u2013548 (1987).","journal-title":"J. Natl Cancer Inst."},{"key":"e_1_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2003.11.037"},{"key":"e_1_3_3_63_1","doi-asserted-by":"publisher","DOI":"10.1177\/030089160208800616"},{"issue":"20","key":"e_1_3_3_64_1","first-page":"7449","article-title":"2-difluoromethylornithine and dehydroepiandrosterone inhibit mammary tumor progression but not mammary or prostate tumor initiation in C3(1)\/SV40 T\/t-antigen transgenic mice","volume":"61","author":"Green JE","year":"2001","unstructured":"Green JE , ShibataMA, ShibataEet al. 2-difluoromethylornithine and dehydroepiandrosterone inhibit mammary tumor progression but not mammary or prostate tumor initiation in C3(1)\/SV40 T\/t-antigen transgenic mice. Cancer Res.61(20), 7449\u20137455 (2001).","journal-title":"Cancer Res."},{"issue":"18","key":"e_1_3_3_65_1","first-page":"5125","article-title":"Chemoprevention of prostate carcinogenesis by alpha-difluoromethylornithine in TRAMP mice","volume":"60","author":"Gupta S","year":"2000","unstructured":"Gupta S , AhmadN, MarengoSR, MacLennanGT, GreenbergNM, MukhtarH. Chemoprevention of prostate carcinogenesis by alpha-difluoromethylornithine in TRAMP mice. Cancer Res.60(18), 5125\u20135133 (2000).","journal-title":"Cancer Res."},{"key":"e_1_3_3_66_1","doi-asserted-by":"publisher","DOI":"10.1002\/pros.2990150303"},{"issue":"1","key":"e_1_3_3_67_1","first-page":"11","article-title":"Effect of early and delayed difluoromethylornithine pretreatment upon cyclophosphamide chemotherapy","volume":"8","author":"Johnson M","year":"1990","unstructured":"Johnson M , ShawM, RubensteinM, GuinanP. Effect of early and delayed difluoromethylornithine pretreatment upon cyclophosphamide chemotherapy. Clin. Physiol. Biochem.8(1), 11\u201315 (1990).","journal-title":"Clin. Physiol. Biochem."},{"key":"e_1_3_3_68_1","doi-asserted-by":"publisher","DOI":"10.1002\/pros.2990150206"},{"key":"e_1_3_3_69_1","doi-asserted-by":"publisher","DOI":"10.1002\/pros.2990110111"},{"key":"e_1_3_3_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/0090-4295(86)90154-8"},{"key":"e_1_3_3_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3835(82)90093-3"},{"key":"e_1_3_3_72_1","doi-asserted-by":"publisher","DOI":"10.1002\/pros.2990030408"},{"key":"e_1_3_3_73_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-2539"},{"key":"e_1_3_3_74_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.2768"},{"key":"e_1_3_3_75_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-2968"},{"key":"e_1_3_3_76_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-6866"},{"key":"e_1_3_3_77_1","volume-title":"17th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology","author":"Levin VA","year":"2012","unstructured":"Levin VA , HessKR, ChoucairAAet al. Final report for evaluable patients treated on DM92\u2013035, Phase III randomized study of post-irradiation PCV versus DFMO-PCV, for anaplastic gliomas. Presented at: 17th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. Washington, DC, USA, 15\u201318 November 2012."},{"key":"e_1_3_3_78_1","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.CAPR-12-0429"},{"issue":"12","key":"e_1_3_3_79_1","first-page":"1281","article-title":"Chemoprevention of human actinic keratoses by topical 2-(difluoromethyl)-dl-ornithine","volume":"9","author":"Alberts DS","year":"2000","unstructured":"Alberts DS , DorrRT, EinspahrJGet al. Chemoprevention of human actinic keratoses by topical 2-(difluoromethyl)-dl-ornithine. Cancer Epidemiol. Biomarkers Prev.9(12), 1281\u20131286 (2000).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"e_1_3_3_80_1","first-page":"191","article-title":"Alpha-difluoromethylornithine induction of apoptosis: a mechanism which reverses pre-established cell proliferation and cancer initiation in esophageal carcinogenesis in zinc-deficient rats","volume":"10","author":"Fong LY","year":"2001","unstructured":"Fong LY , NguyenVT, PeggAE, MageePN. Alpha-difluoromethylornithine induction of apoptosis: a mechanism which reverses pre-established cell proliferation and cancer initiation in esophageal carcinogenesis in zinc-deficient rats. Cancer Epidemiol. Biomarkers Prev.10, 191\u2013199 (2001).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"e_1_3_3_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.spen.2014.12.002"},{"key":"e_1_3_3_82_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-015-1799-9"},{"issue":"12","key":"e_1_3_3_83_1","first-page":"1281","article-title":"Chemoprevention of human actinic keratoses by topical 2-(difluoromethyl)-dl-ornithine","volume":"9","author":"Alberts DS","year":"2000","unstructured":"Alberts DS , DorrRT, EinspahrJGet al. Chemoprevention of human actinic keratoses by topical 2-(difluoromethyl)-dl-ornithine. Cancer Epidemiol. Biomarkers Prev.9(12), 1281\u20131286 (2000).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"e_1_3_3_84_1","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.CAPR-09-0096"},{"key":"e_1_3_3_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2015.10.021"},{"key":"e_1_3_3_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2015.12.009"},{"key":"e_1_3_3_87_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon.15.63"},{"key":"e_1_3_3_88_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon.14.91"},{"key":"e_1_3_3_89_1","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.CAPR-15-0432"},{"key":"e_1_3_3_90_1","doi-asserted-by":"publisher","DOI":"10.1097\/CAD.0b013e328359affd"},{"key":"e_1_3_3_91_1","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgh209"},{"issue":"11","key":"e_1_3_3_92_1","first-page":"989","article-title":"A randomized, placebo-controlled trial of low-dose alpha-difluoromethylornithinein individuals at risk for colorectal cancer","volume":"7","author":"Love RR","year":"1998","unstructured":"Love RR , JacobyR, NewtonMAet al. A randomized, placebo-controlled trial of low-dose alpha-difluoromethylornithinein individuals at risk for colorectal cancer. Cancer Epidemiol. Biomarkers Prev.7(11), 989\u2013992 (1998).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"e_1_3_3_93_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/86.15.1122"},{"key":"e_1_3_3_94_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/90.16.1212"},{"key":"e_1_3_3_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2011.09.007"},{"key":"e_1_3_3_96_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-10858-7_4"},{"key":"e_1_3_3_97_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-12-0305"},{"key":"e_1_3_3_98_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-2235"},{"key":"e_1_3_3_99_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.pcan.4500420"},{"key":"e_1_3_3_100_1","doi-asserted-by":"publisher","DOI":"10.2174\/13816128113199990029"},{"key":"e_1_3_3_101_1","doi-asserted-by":"publisher","DOI":"10.1002\/pros.23142"},{"issue":"4","key":"e_1_3_3_102_1","first-page":"196","article-title":"[Therapy with inhibitors of polyamine biosynthesis in refractory prostatic carcinoma. An experimental and clinical study]","volume":"8","author":"Dunzendorfer U","year":"1985","unstructured":"Dunzendorfer U , Kn\u00f6nerM. [Therapy with inhibitors of polyamine biosynthesis in refractory prostatic carcinoma. An experimental and clinical study]. Onkologie8(4), 196\u2013200 (1985).","journal-title":"Onkologie"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fon-2016-0266","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T06:44:27Z","timestamp":1719125067000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fon-2016-0266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,27]]},"references-count":101,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,4,30]]}},"alternative-id":["10.2217\/fon-2016-0266"],"URL":"https:\/\/doi.org\/10.2217\/fon-2016-0266","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,27]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2016-06-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-01-11","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-01-27","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}